RxDoctor Payments Data

Jaan Kelly, PA

Medical · Knoxville, TNNPI 1831189190

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 40 manufacturers reported payments, led by AbbVie at 26.1% of the total. 2025 is the largest year on record at $2,017, 6.3 times the $321 reported in 2021. Among medical clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,964in general payments, 2019–2025

Across 302 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$853
  • Revance Therapeutics, Inc.$394
  • Axsome Therapeutics, Inc.$275
  • Amgen$246
  • Lilly USA, LLC$231
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,83598%
  • Education$1292%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,964 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$5,347
Medicare patients
32
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$58,614
JardianceEmpagliflozin17$17,119
Gabapentin60$951
SynthroidLevothyroxine Sodium11$561
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$450
Levothyroxine Sodium50$337
Albuterol Sulfate HfaAlbuterol Sulfate17$318
Oxycodone Hcl16$302
Omeprazole16$240
Fluticasone Propionate11$220
Rosuvastatin Calcium29$212
Pregabalin16$193
Amlodipine Besylate44$192
Venlafaxine Hcl12$192
Ezetimibe15$185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$231$58,61457 claims
Boehringer IngelheimJardiance$70$17,11917 claims
AbbVieSynthroid$1,555$56111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.

Other medical in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →